Retinal hemorrhages in anastrozole users
- PMID: 18451730
- DOI: 10.1097/OPX.0b013e31816bea3b
Retinal hemorrhages in anastrozole users
Abstract
Purpose: To determine whether women using anastrozole (an aromatase inhibitor, which suppresses estrogen synthesis) are likely to have retinal hemorrhages.
Methods: Fundus photographs were obtained for a study comparing effects on vision and the eye of anastrozole (1 mg/d) and tamoxifen (20 mg/d) for women receiving adjuvant endocrine therapy for early-stage breast cancer. Photographs (2 eyes per subject) were evaluated for hemorrhages by an ophthalmologist masked from identifying subject information. The presence of hemorrhages was assessed for 35 anastrozole users, 38 amenorrheic tamoxifen users, and 53 amenorrheic (peri- or postmenopausal) control subjects not using any endocrine medication. The age range was 43 to 69 years; only subjects reporting normal vision and healthy eyes were recruited. Photographs from 36 tamoxifen users from a previous study also were assessed. Views of the fundus extended appreciably beyond the posterior pole for all tamoxifen and anastrozole users, and for 38 of the control subjects. Photographic assessments were compared with medical history and blood pressure data, and optical coherence tomography was used for quantifying aspects of foveal shape that might be affected by vitreoretinal traction.
Results: Four anastrozole users and no contemporaneous tamoxifen users but one previously tested tamoxifen user had retinal hemorrhages, in each case within the posterior pole. Two anastrozole users had a flame hemorrhage (in the retinal nerve fiber layer), and two had a blot hemorrhage (deeper in the retina). No control subjects were observed to have hemorrhages.
Conclusions: Anastrozole use appears to be associated with an increased prevalence of retinal hemorrhages. The hemorrhages may mark systemic vascular compromise resulting from estrogen depletion, and/or they may be consequences of vitreoretinal traction resulting from estrogen depletion. They may also depend on the use of medications for controlling common anastrozole-induced side effects. Prospective studies need to be conducted with larger numbers of subjects.
Similar articles
-
Anastrozole for breast cancer: recent advances and ongoing challenges.Expert Rev Anticancer Ther. 2006 Jun;6(6):839-48. doi: 10.1586/14737140.6.6.839. Expert Rev Anticancer Ther. 2006. PMID: 16761927 Review.
-
Anastrozole: new indication. Adjuvant treatment of non metastatic breast cancer: useful for some patients.Prescrire Int. 2005 Apr;14(76):43-4. Prescrire Int. 2005. PMID: 15875334
-
Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.Breast Cancer Res Treat. 2007 Dec;106(2):161-70. doi: 10.1007/s10549-006-9486-3. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260092 Free PMC article.
-
Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.Onkologie. 2009 Jul;32(7):421-3. doi: 10.1159/000218369. Epub 2009 Jun 12. Onkologie. 2009. PMID: 19556821
-
Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.Expert Rev Anticancer Ther. 2008 Dec;8(12):1871-81. doi: 10.1586/14737140.8.12.1871. Expert Rev Anticancer Ther. 2008. PMID: 19046107 Review.
Cited by
-
Side Effects of Novel Anticancer Drugs on the Posterior Segment of the Eye: A Review of the Literature.J Pers Med. 2024 Dec 19;14(12):1160. doi: 10.3390/jpm14121160. J Pers Med. 2024. PMID: 39728071 Free PMC article. Review.
-
A system for computerised retinal haemorrhage analysis.BMC Res Notes. 2009 Sep 28;2:196. doi: 10.1186/1756-0500-2-196. BMC Res Notes. 2009. PMID: 19785742 Free PMC article.
-
Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience.J Korean Med Sci. 2018 Feb 12;33(7):e55. doi: 10.3346/jkms.2018.33.e55. J Korean Med Sci. 2018. PMID: 29359539 Free PMC article.
-
Vitreo-retinal traction and anastrozole use.Breast Cancer Res Treat. 2009 Sep;117(1):9-16. doi: 10.1007/s10549-008-0156-5. Epub 2008 Aug 20. Breast Cancer Res Treat. 2009. PMID: 18712596 Free PMC article.
-
Review of the Literature on Ocular Complications Associated With Aromatase Inhibitor Use.Cureus. 2021 Aug 30;13(8):e17565. doi: 10.7759/cureus.17565. eCollection 2021 Aug. Cureus. 2021. PMID: 34646621 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical